These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8425305)

  • 21. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrocardiological profile and proarrhythmic effects of quinidine, verapamil and their combination: a mapping study.
    Dhein S; Schott M; Gottwald E; Klaus W
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Jul; 352(1):94-101. PubMed ID: 7477431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Holmes B; Heel RC
    Drugs; 1985 Jan; 29(1):1-33. PubMed ID: 3882390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation.
    van Brakel TJ; Hermans JJ; Accord RE; Schotten U; Smits JF; Allessie MA; Maessen JG
    J Cardiovasc Electrophysiol; 2009 Feb; 20(2):207-15. PubMed ID: 19175851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
    Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G
    Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of E-4031, a new class III antiarrhythmic drug, on reentrant ventricular arrhythmias: comparison with conventional class I drugs.
    Ogawa S; Mitamura H; Katoh H
    Cardiovasc Drugs Ther; 1993 Aug; 7 Suppl 3():621-6. PubMed ID: 8251432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class I antiarrhythmics inhibit Na+ absorption and Cl- secretion in rabbit descending colon epithelium.
    Plass H; Charisius M; Wyskovsky W; Amor F; Turnheim K; Wiener H
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):492-9. PubMed ID: 16012869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New antiarrhythmic drugs.
    Nestico PF; Morganroth J; Horowitz LN
    Drugs; 1988 Mar; 35(3):286-319. PubMed ID: 3286214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
    Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
    Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of quinidine, flecainide, and cibenzoline on anisotropic conduction in the isolated porcine heart.
    Lacroix D; Delfaut P; Adamantidis M; Cardinal R; Klug D; Kacet S; Dupuis B
    J Cardiovasc Electrophysiol; 1998 Jan; 9(1):55-69. PubMed ID: 9475578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessments of the QT/QRS restitution in perfused guinea-pig heart can discriminate safe and arrhythmogenic drugs.
    Osadchii OE
    J Pharmacol Toxicol Methods; 2017 Sep; 87():27-37. PubMed ID: 28552278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy.
    Ermakov S; Gerstenfeld EP; Svetlichnaya Y; Scheinman MM
    Heart Rhythm; 2017 Apr; 14(4):564-569. PubMed ID: 27939893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of flecainide and D-sotalol on myocardial conduction and refractoriness: relation to antiarrhythmic and proarrhythmic drug effects.
    Kidwell GA; Gonzalez MD
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):621-32. PubMed ID: 7681909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prearrhythmia: changes preceding arrhythmia, new aspects by epicardial mapping.
    Dhein S; Müller A; Klaus W
    Basic Res Cardiol; 1990; 85(3):285-96. PubMed ID: 2383222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade by antiarrhythmic drugs of glibenclamide-sensitive K+ channels in Xenopus oocytes.
    Sakuta H; Okamoto K; Watanabe Y
    Br J Pharmacol; 1992 Dec; 107(4):1061-7. PubMed ID: 1361399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
    Sarubbi B; Ducceschi V; Briglia N; Esposito R; Mayer MS; Scialdone A; Santangelo L; Iacono A
    Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram.
    Morganroth J; Horowitz LN
    Am J Cardiol; 1984 Feb; 53(5):89B-94B. PubMed ID: 6695821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic and electrophysiologic actions of flecainide in animal models.
    Kvam DC; Banitt EH; Schmid JR
    Am J Cardiol; 1984 Feb; 53(5):22B-25B. PubMed ID: 6695815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.